Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial (Q33401123)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial |
scientific article |
Statements
1 reference
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial (English)
1 reference
Tanios Bekaii-Saab
1 reference
Allyson J Ocean
1 reference
Kenneth L Pennington
1 reference
Michael J Guarino
1 reference
Arif Sheikh
1 reference
Aldo N Serafini
1 reference
Daniel Lee
1 reference
Max W Sung
1 reference
Seza A Gulec
1 reference
Stanley J Goldsmith
1 reference
Timothy Manzone
1 reference
Michael Holt
1 reference
Bert H O'Neil
1 reference
Nathan Hall
1 reference
Alberto J Montero
1 reference
John Kauh
1 reference
David V Gold
1 reference
Heather Horne
1 reference
William A Wegener
1 reference
David M Goldenberg
1 reference
8 May 2012
1 reference
1 reference
118
1 reference
22
1 reference
5497-5506
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference